Cross-linking KXL System

Avedro-Glaukos

Learn more about Cross-linking KXL System

Avedro-Glaukos

Avedro-Glaukos is the manufacturer of the FDA-approved KXL system, designed for treating keratoconus and other forms of corneal ectasia.

This innovative corneal cross-linking technique offers:

Who Can Benefit from Corneal Cross-Linking?

The KXL system delivers a uniform UVA light dose in a circular pattern over a specific corneal area, ensuring targeted and effective treatment.

Available countries

Colombia, Ecuador, Central America and the Caribbean.

Technical data

Sanitary registration

Post-Sale Service

Technical support with an engineer accredited by Avedro-Glaukos and registered with INVIMA.